ALFA Filings
Every announcement, straight from the exchange
Every Vivanza Biosciences other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Vivanza Biosciences Ltd has filed a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026.
Vivanza Biosciences declared that its statutory auditors issued an audit report with an unmodified opinion. This covers results for the quarter and year ended March 31, 2026.
Vivanza Biosciences confirmed non-applicability of SEBI's Related Party Transaction disclosures for March 2026. The company remains below regulatory thresholds for mandatory reporting.
Vivanza Biosciences Ltd announced the non-applicability of the Annual Secretarial Compliance Report for the year ended March 31, 2026. The company is exempt under SEBI Regulation 15(2) as its paid-up capital is ₹4 Crore and net worth is approximately ₹4.02 Crore, both falling below the mandatory reporting thresholds.
Vivanza Biosciences Ltd submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The registrar, Purva Sharegistry (I) Pvt Ltd, confirmed that nil share certificates were received for dematerialisation during the quarter. This is a routine regulatory disclosure with no material financial impact.